Financhill
Sell
30

OCX Quote, Financials, Valuation and Earnings

Last price:
$2.08
Seasonality move :
11.62%
Day range:
$2.08 - $2.15
52-week range:
$1.97 - $3.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
31.62x
P/B ratio:
3.61x
Volume:
28.1K
Avg. volume:
92.7K
1-year change:
-39.71%
Market cap:
$35M
Revenue:
$1.5M
EPS (TTM):
-$4.54

Earnings Data

Next earnings date for OCX
Apr 11
2025
Most recent earnings per share
-$0.98
Missed by $0.98
(Nov 12/2024)
Consensus Estimate
--
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

OCX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/11/2025 Q1 $158.6K -- -- -- --
12/31/2024 Q4 $101.7K -- -- -- --
11/12/2024 Q3 $168.3K $115K -$0.98 -- --
08/08/2024 Q2 $312.4K $104K -$0.36 -$0.37 $0.01
05/15/2024 Q1 $350K $176K -$1.13 -$0.57 -$0.56
03/29/2024 Q4 $316.7K $314K -$2.07 -- --
11/09/2023 Q3 $312.5K $429K -$0.81 -$0.78 -$0.03
08/10/2023 Q2 $350K $463K -$1.07 -$0.59 -$0.48
05/11/2023 Q1 $336.4K $297K $0.40 -$1.30 $1.70
03/31/2023 Q4 $1.4M $274K -$8.03 -$1.60 -$6.43
11/10/2022 Q3 $1.5M $67K -$1.62 -$2.33 $0.71
08/10/2022 Q2 -- $237K -$1.48 -- --
05/11/2022 Q1 -- $380K -$2.20 -- --
03/10/2022 Q4 -- -$1.9M -$7.80 -- --
11/09/2021 Q3 -- $984K -$3.00 -- --
08/10/2021 Q2 -- $2M -$2.40 -- --
05/17/2021 Q1 -- $1.1M -$1.00 -- --
03/16/2021 Q4 -- $503K -$1.80 -- --
11/12/2020 Q3 -- $555K -$2.00 -- --
07/29/2020 Q2 -- $143K -$2.80 -- --
05/12/2020 Q1 -- $16K -$2.60 -- --
03/25/2020 Q4 -- -- -$3.00 -- --
11/14/2019 Q3 -- -- -$2.00 -- --
08/14/2019 Q2 -- -- -$2.07 -- --
04/01/2019 Q1 -- -- -$1.60 -- --
12/31/2018 Q4 -- -- -$2.20 -- --
11/13/2018 Q3 -- -- -$1.40 -- --
08/14/2018 Q2 -- -- -$2.40 -- --
04/02/2018 Q1 -- -- -$2.40 -- --
12/31/2017 Q4 -- -- -$2.60 -- --
11/14/2017 Q3 -- -- -$4.40 -- --
08/14/2017 Q2 -- -- -$2.60 -- --
03/31/2017 Q1 -- -- -$3.20 -- --
12/31/2016 Q4 -- -- -$2.20 -- --
09/30/2016 Q3 -- -- -$2.00 -- --
06/30/2016 Q2 -- -- -$2.00 -- --
03/31/2016 Q1 -- -- -$2.40 -- --
12/31/2015 Q4 -- -- -$2.80 -- --
09/30/2015 Q3 -- -- -$1.90 -- --
06/30/2015 Q2 -- -- -$4.35 -- --
03/31/2015 Q1 -- -- -$4.22 -- --

OncoCyte Earnings Questions

  • How Much did OncoCyte Generate in Revenue Last Quarter?

    OncoCyte reported $115K worth of top line sales in its most recent quarter.

  • Did OncoCyte Beat Earnings Last Quarter?

    OncoCyte announced earnings per share of -$0.98 which represents a miss of analyst forecast a -- per share.

  • Is OncoCyte Profitable?

    OncoCyte reported $50K that represents $0.00 per share over the last quarter.

  • What is the Analyst Consensus for OncoCyte EPS Next Year?

    OncoCyte's earnings are forecast to decrease from -$3.75 per share to -- per share next year representing a decrease of -58.13%.

  • When is OncoCyte's Earnings Date?

    OncoCyte's next earnings date is April 11, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is AT&T Stock Dropping?
Why Is AT&T Stock Dropping?

The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…

Is American Express Stock Going Lower?
Is American Express Stock Going Lower?

American Express Company (NYSE:AXP) has long been a Buffett favorite…

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 18

Quantum [QMCO] is down 15.61% over the past day.

Buy
51
QRVO alert for Jan 18

Qorvo [QRVO] is up 14.47% over the past day.

Sell
31
ATEX alert for Jan 18

Anterix [ATEX] is up 11.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock